Csenge Advisory Group purchased a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 7,784 shares of the company’s stock, valued at approximately $1,295,000.
Several other institutional investors have also made changes to their positions in the company. Assetmark Inc. grew its stake in shares of Astera Labs by 374.1% in the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after buying an additional 101 shares in the last quarter. Hilltop National Bank raised its position in Astera Labs by 100.0% during the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after acquiring an additional 100 shares in the last quarter. Aventura Private Wealth LLC bought a new position in Astera Labs during the fourth quarter valued at approximately $33,000. Wexford Capital LP acquired a new stake in Astera Labs in the third quarter valued at approximately $39,000. Finally, National Bank of Canada FI lifted its stake in Astera Labs by 159.0% in the third quarter. National Bank of Canada FI now owns 202 shares of the company’s stock valued at $39,000 after acquiring an additional 124 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.
Insiders Place Their Bets
In related news, General Counsel Philip Mazzara sold 14,076 shares of the stock in a transaction that occurred on Monday, May 18th. The stock was sold at an average price of $231.78, for a total transaction of $3,262,535.28. Following the completion of the sale, the general counsel owned 104,139 shares in the company, valued at $24,137,337.42. This represents a 11.91% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $200.03, for a total value of $701,105.15. Following the sale, the director owned 63,639 shares of the company’s stock, valued at approximately $12,729,709.17. The trade was a 5.22% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 1,635,461 shares of company stock valued at $288,735,776. 12.50% of the stock is owned by company insiders.
Wall Street Analysts Forecast Growth
Read Our Latest Report on ALAB
Key Astera Labs News
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Wall Street optimism and a fresh analyst “buy” call helped fuel the rally, with investors viewing Astera Labs as a strong AI play. Astera Labs (ALAB) Soars 13% on Analyst ‘Buy’ Reco
- Positive Sentiment: Management commentary about a new switch timeline and potential revenue opportunities in optical networking boosted sentiment around future growth catalysts. Here’s why Astera Labs’ stock just staged a big gain
- Positive Sentiment: Traders also pointed to a “Power Inflow” alert and unusually heavy call-option buying, suggesting aggressive bullish positioning and momentum chasing in the stock. Astera Labs Shares Rise Over 6 Percent After Key Trading Signal
- Positive Sentiment: The stock is also being bid up after a Barron’s report said it is on pace for a record high, reinforcing the market’s view that Astera Labs is emerging as a notable AI infrastructure winner. Astera Labs Stock on Pace for Record High. Why It’s Up Double Digits for a Second Day.
Astera Labs Trading Up 17.7%
Shares of Astera Labs stock opened at $287.48 on Thursday. The firm has a fifty day simple moving average of $163.12 and a 200-day simple moving average of $157.97. Astera Labs, Inc. has a 1-year low of $84.78 and a 1-year high of $287.70. The stock has a market capitalization of $49.28 billion, a price-to-earnings ratio of 194.24, a PEG ratio of 3.23 and a beta of 3.35.
Astera Labs (NASDAQ:ALAB – Get Free Report) last posted its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. The business had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. Astera Labs’s revenue was up 93.5% compared to the same quarter last year. During the same period last year, the business posted $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, research analysts predict that Astera Labs, Inc. will post 1.84 earnings per share for the current year.
About Astera Labs
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Articles
- Five stocks we like better than Astera Labs
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
